Inventor
REZA FATHI
Inventor
US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
Y02ATechnologies for adaptation to climate change16%
A61MDevices for introducing media into, or onto, the body11%
PatentTitleYear
12,569,475Method for eradicating helicobacter pylori infection in patients regardless of body mass index202612,551,469Sphingosine kinase 2 inhibitor for treating coronavirus infection202612,502,381Serine protease inhibitor for treating coronavirus infection202512,370,206Therapy for inhibition of single-stranded RNA virus replication202512,115,150Biomarkers of coronavirus pneumonia202411,931,463All-in-one fixed-dose combination for treating 202411,918,560Serine protease inhibitor for treating coronavirus infection202411,878,011Method for eradicating 202411,786,541Inhibitor of sphingosine kinase 2 for treating Ebola202311,633,385Combination compositions for treatment of cancer202311,590,154Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections202311,471,448Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia202211,364,227Sphingosine kinase 2 inhibitor for treating coronavirus infection202211,135,172Rifabutin-based compositions and methods for treating 2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to REDHILL BIOPHARMA LTD (14)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REDHILL BIOPHARMA LTD | 14 | 2021–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 14 | 2021–2026 |